MEDOGEN

This brand name is authorized in Nigeria.

Active ingredients

The drug MEDOGEN contains one active pharmaceutical ingredient (API):

1	Medroxyprogesterone UNII C2QI4IOI2G - MEDROXYPROGESTERONE ACETATE
	Medroxyprogesterone acetate exerts anti-oestrogenic, anti-androgenic and antigonadotrophic effects.
	Read more about Medroxyprogesterone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-101057	Suspension for injection	Medogen 150 mg/mL Suspension for Injection+++ INJ_SUSP 150 mg/mL 1 mL x 1 vial ,1 mL x 20 vials	Sterile suspension for injection White to off-white, sterile suspension for injection 3 NF-PP-389022 MEDOGEN 150mg/ml SUSPENSION FOR INJECTION MEDROXYPROGESTERONE ACETATE 150mg medroxyprogesterone acetate A4-101057 Drugs Imported Products 1ml x 1vial ,1ml x 20 vials Prescription Only Medicine (POM) 11/22/2023 DEEP K. TYAGI FOUNDATION NIGERIA, 4th FLOOR, A.G LEVENTIS BUILDING, IDDO HOUSE, IDDO, LAGOS 9094998782 info@dktnigeria.org INCEPTA PHARMACEUTICALS LTD, 40 Shahid Tajuddin Ahmed Sarani, Tejgaon I/A Dhaka - 1208, Bangladesh., Bangladesh	31/10/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03AC06	Medroxyprogesterone	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AC Progestogens
Discover more medicines within G03AC06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-101057